News: Gold medal-winning treatment for skiing enthusiasts

 

Skiing enthusiasts suffering with chronic soft tissue-related injuries can ensure they are fit for the forthcoming winter season by taking advantage of a brand-new medical treatment technology that helped Norwegian Aksel Lund Svindal return to full fitness ahead of his gold medal-winning performance at the Winter Olympics in Canada.

Extracorporeal Shockwave Therapy (ESWT) has proved efficient when treating painful injuries in the foot, ankle, hip, shoulder and elbow. Conditions that include Tennis Elbow, Plantar Fasciitis, Achilles Tendonitis and calcification of the shoulder tendons - all conditions associated with skiing - have been cured using ESWT technology.

The clinical results recorded by the leading ESWT device in Europe, the Swiss DolorClast, have been so impressive that Svindal turned to the device to help him overcome injury before the recent Winter Olympics.

He said: "It (Swiss Dolorclast) allowed me to recover from an injury earlier than expected. The treatment allowed me to participate in the ski alpine world cups in Lake Louise, Beaver Creek and Val d'Isere and laid the ground for me to win the Super G in Groeden and the Super G gold medal at the Winter Olympics."

The Swiss DolorClast passes low-energy shockwaves through the skin to initiate an inflammation-like response in the injured soft tissue. This prompts the body to respond naturally by increasing blood circulation, the number of blood vessels and therefore metabolism in the injured tissue. This accelerates the body's natural healing process by increasing cell generation and dissolving calcium deposits.

And in a move that will be seen as a boost for skiing enthusiasts ahead of the winter skiing season, a network of clinicians has now been established to offer a Swiss DolorClast treatment service to a wider audience in the UK.

Jim Westwood, the man responsible for driving ESWT technology in the UK, said: "Soft tissue injuries are common in skiing and, until the Swiss DolorClast came along, clinicians didn't have anything else they could offer patients that had tried all the other forms of conventional treatment for their chronic tendon or soft tissue inflammation problems.

"But ESWT technology is a real breakthrough. It gives patients pain relief without the need for a surgical procedure and treatment sessions with the Swiss DolorClast only take about 15 minutes, there is no need for anaesthetic, tablets, lengthy rehabilitation, loss of mobility or time off work. It's a very exciting development for people who enjoy skiing but are worried they won't be able to enjoy the winter season."

Back to Latest News

 

EDITORS’ NOTES

Spectrum Technology UK Ltd is the exclusive distributor for the Swiss DolorClast Extracorporeal Shockwave Therapy device in the UK

NICE advised that radial Extracorporeal Shockwave Therapy (ESWT) is considered a safe treatment option for the treatment of Plantar Fasciitis, Achilles Tendonopathy and Tennis Elbow in August 2009

Spectrum Technology's Swiss DolorClast device has amassed more clinical trial data between levels one and two than any other Extracorporeal Shockwave Therapy device in the world

The Swiss DolorClast device is widely used in top-flight sport to treat and manage injuries. The device is used by a number of football teams in the English Premier League and was also used by athletes at the recent Olympic Games in China and Canada

The Swiss DolorClast is the only ESWT device to be actively promoted in the UK that administers low-energy impulses during treatment. As yet, there have been no reported ruptures as a result of using the Swiss DolorClast

The Swiss DolorClast Extracorporeal Shockwave Therapy device was first launched in 2000. It was designed and continues to be manufactured by Electro Medical Systems (EMS) in Switzerland

The Swiss DolorClast device delivers shockwaves to the injured area of the body by converting kinetic energy into a shockwave - an action that is clearly illustrated by Newton's Cradle

Spectrum Technology is proud to conduct its clinical trials with the support of some of the UK's leading medical professionals. This list includes Professor Nicola Maffulli, one of the most pre-eminent sports medicine and orthopaedic consultants in the UK